Cargando…
Management of patients with hormone receptor–positive breast cancer with visceral disease: challenges and treatment options
Endocrine therapy is an important treatment option for women with hormone receptor–positive (HR+) advanced breast cancer (ABC), yet many tumors are either intrinsically resistant or develop resistance to these therapies. Treatment of patients with ABC presenting with visceral metastases, which is as...
Autor principal: | Harb, Wael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310719/ https://www.ncbi.nlm.nih.gov/pubmed/25653556 http://dx.doi.org/10.2147/CMAR.S72592 |
Ejemplares similares
-
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies
por: Robertson, John F. R., et al.
Publicado: (2021) -
Patient Perspectives on Treatment Options for Older Women With Hormone Receptor–Positive Breast Cancer: A Qualitative Study
por: Wang, Ton, et al.
Publicado: (2020) -
Treatment Considerations for the Management of Patients With Hormone Receptor–Positive Metastatic Breast Cancer
por: Visovsky, Constance
Publicado: (2014) -
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
por: Dobovišek, Luka, et al.
Publicado: (2020) -
Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer
por: Bowles, Harmony J., et al.
Publicado: (2015)